NO20011371L - Kjemokinreseptorantagonist og cyklosporin i kombinert terapi - Google Patents

Kjemokinreseptorantagonist og cyklosporin i kombinert terapi

Info

Publication number: NO20011371L
Authority: NO; Norway
Prior art keywords: cyclosporin; receptor antagonist; chemokine receptor; pharmaceutical composition; combined therapy
Prior art date: 1998-09-18

Application number

NO20011371A

Other languages

English (en)

Norwegian (no)

Other versions

NO20011371D0 (no

Inventor

Hermann-Joseph Grone

Peter J Nelson

Amanda Proudfoot

Timothy N C Wells

Original Assignee

Applied Research Systems

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-18

Filing date

2001-03-16

Publication date

2001-03-16

2001-03-16 Application filed by Applied Research Systems filed Critical Applied Research Systems

2001-03-16 Publication of NO20011371D0 publication Critical patent/NO20011371D0/no

2001-03-16 Publication of NO20011371L publication Critical patent/NO20011371L/no

Links

PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 title abstract 3
229930105110 Cyclosporin A Natural products 0.000 title abstract 3
108010036949 Cyclosporine Proteins 0.000 title abstract 3
229960001265 ciclosporin Drugs 0.000 title abstract 3
229940122444 Chemokine receptor antagonist Drugs 0.000 title abstract 2
239000002559 chemokine receptor antagonist Substances 0.000 title abstract 2
229930182912 cyclosporin Natural products 0.000 title abstract 2
238000002648 combination therapy Methods 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 abstract 3
108010023347 Met- RANTES Proteins 0.000 abstract 1
206010052779 Transplant rejections Diseases 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
210000000056 organ Anatomy 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Toxicology (AREA)
Molecular Biology (AREA)
Animal Behavior & Ethology (AREA)
Biochemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Transplantation (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

NO20011371A 1998-09-18 2001-03-16 Kjemokinreseptorantagonist og cyklosporin i kombinert terapi NO20011371L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP98117697A EP1000626A1 (en)	1998-09-18	1998-09-18	Chemokine receptor antagonist and cyclosporin in combined therapy
PCT/EP1999/006844 WO2000016796A1 (en)	1998-09-18	1999-09-16	Chemokine receptor antagonist and cyclosporin in combined therapy

Publications (2)

Publication Number	Publication Date
NO20011371D0 NO20011371D0 (no)	2001-03-16
NO20011371L true NO20011371L (no)	2001-03-16

Family

ID=8232654

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20011371A NO20011371L (no)	1998-09-18	2001-03-16	Kjemokinreseptorantagonist og cyklosporin i kombinert terapi

Country Status (23)

Country	Link
US (1)	US6902728B1 (ru)
EP (2)	EP1000626A1 (ru)
JP (1)	JP2003519082A (ru)
KR (1)	KR100613950B1 (ru)
CN (1)	CN1177613C (ru)
AR (1)	AR021810A1 (ru)
AT (1)	ATE227582T1 (ru)
AU (1)	AU766595B2 (ru)
BR (1)	BR9913846A (ru)
CA (1)	CA2344370A1 (ru)
DE (1)	DE69903964T2 (ru)
DK (1)	DK1113811T3 (ru)
EA (1)	EA003181B1 (ru)
EE (1)	EE04705B1 (ru)
ES (1)	ES2186411T3 (ru)
HK (1)	HK1041225B (ru)
IL (2)	IL141899A0 (ru)
NO (1)	NO20011371L (ru)
PT (1)	PT1113811E (ru)
SI (1)	SI1113811T1 (ru)
UA (1)	UA60379C2 (ru)
WO (1)	WO2000016796A1 (ru)
ZA (1)	ZA200101909B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7259136B2 (en)	1999-04-30	2007-08-21	Amylin Pharmaceuticals, Inc.	Compositions and methods for treating peripheral vascular disease
US6740636B2 (en)	2000-07-31	2004-05-25	Schering Aktiengesellschaft	Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection
LT5132B (lt)	2000-07-31	2004-05-25	Schering Aktiengesellschaft	Nepeptidiniai ccr1 receptorių antagonistai derinyje su ciklosporinu a širdies transplanto atmetimui gydyti
ES2453592T3 (es)	2007-08-02	2014-04-08	Novimmune Sa	Anticuerpos anti-RANTES y métodos de uso de los mismos
JP6733968B2 (ja) *	2015-08-31	2020-08-05	日立化成株式会社	腎移植後合併症を評価するための分子法
DE112016003948T5 (de)	2015-08-31	2018-05-09	City Of Sapporo	Molekulare verfahren zum beurteilen einer urothelialen erkrankung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI972433A0 (fi) *	1994-12-08	1997-06-06	Glaxo Group Ltd	Rantes-peptidi ja fragmentteja sekä tätä sisältäviä tulehduksen hoitoon soveltuvia koostumuksia
CA2228379A1 (en) *	1995-08-09	1997-02-20	Schering Corporation	Combined use of interleukin-10 and cyclosporin for immunosuppression therapy
WO1998006703A1 (en) *	1996-08-14	1998-02-19	Warner-Lambert Company	2-phenyl benzimidazole derivatives as mcp-1 antagonists
WO1998006751A1 (en) *	1996-08-16	1998-02-19	Research Corporation Technologies, Inc.	Mcp-3, rantes and mip-1alpha receptor antagonists

1998
- 1998-09-18 EP EP98117697A patent/EP1000626A1/en not_active Withdrawn
1999
- 1999-09-16 KR KR1020017003199A patent/KR100613950B1/ko not_active Expired - Fee Related
- 1999-09-16 HK HK02103034.0A patent/HK1041225B/zh not_active IP Right Cessation
- 1999-09-16 AT AT99948760T patent/ATE227582T1/de active
- 1999-09-16 CN CNB998111252A patent/CN1177613C/zh not_active Expired - Fee Related
- 1999-09-16 EE EEP200100159A patent/EE04705B1/xx not_active IP Right Cessation
- 1999-09-16 ES ES99948760T patent/ES2186411T3/es not_active Expired - Lifetime
- 1999-09-16 IL IL141899??A patent/IL141899A0/xx active IP Right Grant
- 1999-09-16 JP JP2000573757A patent/JP2003519082A/ja not_active Withdrawn
- 1999-09-16 SI SI9930157T patent/SI1113811T1/xx unknown
- 1999-09-16 WO PCT/EP1999/006844 patent/WO2000016796A1/en not_active Ceased
- 1999-09-16 EA EA200100366A patent/EA003181B1/ru not_active IP Right Cessation
- 1999-09-16 AU AU61914/99A patent/AU766595B2/en not_active Ceased
- 1999-09-16 AR ARP990104655A patent/AR021810A1/es unknown
- 1999-09-16 DK DK99948760T patent/DK1113811T3/da active
- 1999-09-16 EP EP99948760A patent/EP1113811B1/en not_active Expired - Lifetime
- 1999-09-16 ZA ZA200101909A patent/ZA200101909B/xx unknown
- 1999-09-16 DE DE69903964T patent/DE69903964T2/de not_active Expired - Lifetime
- 1999-09-16 PT PT99948760T patent/PT1113811E/pt unknown
- 1999-09-16 UA UA2001042570A patent/UA60379C2/ru unknown
- 1999-09-16 BR BR9913846-8A patent/BR9913846A/pt not_active Application Discontinuation
- 1999-09-16 CA CA002344370A patent/CA2344370A1/en not_active Abandoned
- 1999-09-16 US US09/787,335 patent/US6902728B1/en not_active Expired - Fee Related
2001
- 2001-03-08 IL IL141899A patent/IL141899A/en not_active IP Right Cessation
- 2001-03-16 NO NO20011371A patent/NO20011371L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2000016796A1 (en)	2000-03-30
IL141899A (en)	2007-12-03
EE04705B1 (et)	2006-10-16
JP2003519082A (ja)	2003-06-17
CN1177613C (zh)	2004-12-01
EP1113811B1 (en)	2002-11-13
EE200100159A (et)	2002-08-15
PT1113811E (pt)	2003-03-31
ATE227582T1 (de)	2002-11-15
CN1319021A (zh)	2001-10-24
HK1041225A1 (en)	2002-07-05
BR9913846A (pt)	2001-06-05
ES2186411T3 (es)	2003-05-01
AU766595B2 (en)	2003-10-16
KR20010075060A (ko)	2001-08-09
EP1113811A1 (en)	2001-07-11
AR021810A1 (es)	2002-08-07
NO20011371D0 (no)	2001-03-16
DE69903964T2 (de)	2003-03-27
EA003181B1 (ru)	2003-02-27
EP1000626A1 (en)	2000-05-17
DE69903964D1 (en)	2002-12-19
KR100613950B1 (ko)	2006-08-18
CA2344370A1 (en)	2000-03-30
US6902728B1 (en)	2005-06-07
DK1113811T3 (da)	2003-03-10
HK1041225B (zh)	2005-04-22
AU6191499A (en)	2000-04-10
UA60379C2 (ru)	2003-10-15
IL141899A0 (en)	2002-03-10
ZA200101909B (en)	2001-09-11
SI1113811T1 (en)	2003-04-30
EA200100366A1 (ru)	2001-08-27

Similar Documents

Publication	Publication Date	Title
ATE291901T1 (de)	2005-04-15	Neue omeprazole und (s)-omeprazole zusammensetzung
GB2357969A (en)	2001-07-11	Improvements in or relating to the treatment of lesions
GR3030924T3 (en)	1999-11-30	Selective system scan for multizone radiotelephone subscriber units.
ATE344801T1 (de)	2006-11-15	Doxorubicin- und daunorubicin-enthaltende, zytotoxische mittel und deren therapeutische anwendung
ATE349438T1 (de)	2007-01-15	Cytotoxische wirkstoffe enthaltend taxane und deren therapeutische anwendung
ATE333896T1 (de)	2006-08-15	Vaskularisierungsinhibitoren
NO20035434D0 (no)	2003-12-05	Behandling eller profylakse av transplantasjonsavst degree tning av insulinproduserende celler
NO20011371L (no)	2001-03-16	Kjemokinreseptorantagonist og cyklosporin i kombinert terapi
ATE152628T1 (de)	1997-05-15	Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
ATE269098T1 (de)	2004-07-15	Verfahren zur vorbeugung von durch zyklosporine oder tacrolimus verursachter nierenvergiftung
HUS1900041I1 (hu)	2019-10-28	Treoszulfán alkalmazása betegek csontvelõ- és vér õssejt-transzplantáció elõtti kondicionálására
Frank et al.	1983	Clinical management: comparison of biobrane, porcine, and human allograft as biologic dressings for burn wounds
UA48986C2 (ru)	2002-09-16	Препарат для лечения сердечно-сосудистых заболеваний "кардиофит"
Hesketh et al.	1995	Adjusting the dose of intravenous ondansetron plus dexamethasone to the emetogenic potential of the chemotherapy regimen.
JP2003519082A5 (ru)	2006-05-25
FR2811229B1 (fr)	2003-08-01	Utilisation d'un polysaccharide excrete par l'espece vibrio diabolicus en cicatrisation osseuse
BR0115364A (pt)	2003-09-23	Tratamento de disfunção sexual
CONWAY et al.	1952	Corticotropin (ACTH) in treatment of keloids
Hoffler et al.	1984	Nitrendipine in hypertension that is difficult to control
Herz	1993	Benzodiazepine prescribing in a community in crisis
Benmeir et al.	1991	Use of buried skin implants after recurrent failure of conventional skin grafting in a massive burn: the renewal of an old technique
JPS5738715A (en)	1982-03-03	Medical composition having activity of prohibiting artery wall from thickening
Anderson	1977	The dilemma of Crohn's disease: management of the posterior wound after coloproctectomy
BENNETT et al.	1969	The role of aggressive surgical treatment in the severely burned patient
HISANO et al.	1977	Experimental use of freeze-dried dura

Legal Events

Date	Code	Title	Description
2008-01-14	CREP	Change of representative	Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS
2009-10-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application